Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

Hyderabad, Amid the gloom caused by COVID-19, one sector which provided a ray of hope was life sciences and turning the challenge into an opportunity, Hyderabad fortified its position as a global force in the world of pharmaceuticals. This southern city, already recognised as a global information technology destination, proved its prowess in the field of pharmaceuticals and biotechnology and emerged as the vaccine capital of the world. Already known as the bulk drug capital of India, Hyderabad witnessed manufacturing of lifesaving COVID-19 drugs like Remdesivir, Hydroxychloroquine and Favipiravir by some of the top pharma companies based here. This was followed by hectic efforts in the city to develop COVID-19 vaccine. In fact, Hyderabad has emerged as the nerve centre of all research and development activities in the country for COVID-19 vaccines and has even attracted international attention. Today, almost all the vaccines being developed in the country for the pandemic have a Hyderabad connect. Four of the six companies developing COVID vaccines in India are based in Hyderabad. <keyword id="149108" type="COMPANY" weightage="20" keywordseo="Bharat-Biotech">Bharat Biotech</keyword> is currently conducting Phase III clinical trials of India's first indigenous COVID-19 vaccine Covaxin. Covaxin is being developed in collaboration with <keyword id="1256547" type="COMPANY" weightage="20" keywordseo="The-Indian-Council-of-Medical-Research">the Indian Council of Medical Research</keyword> (ICMR) - National Institute of Virology (NIV). This indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment facility at Genome Valley here. According to Bharat Biotech, Covaxin has been evaluated in approximately 1,000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results. The Phase III human clinical trials of the vaccine began in November, involving 26,000 volunteers across India. This is India's first and only Phase III efficacy study for a COVID-19 vaccine, and the largest phase III efficacy trial ever conducted for any vaccine in India. "Covaxin has garnered interest from several countries worldwide for supplies and introduction," said Suchitra Ella, Joint Managing Director of Bharat Biotech. In April, Bharat Biotech announced development of CoroFlu, an intranasal vaccine for <keyword id="8698690" type="COMPANY" weightage="20" keywordseo="coronavirus-">Coronavirus.</keyword> University of Wisconsin–Madison and vaccine company FluGen along with Bharat Biotech began the development and testing of CoroFlu. The Hyderabad based company will produce almost 300 million doses of vaccine for global distribution. In May, Bharat Biotech and Thomas Jefferson University of Philadelphia signed an exclusive deal to develop a new vaccine candidate for COVID-19 invented at Jefferson. The novel vaccine was developed using an existing deactivated rabies vaccine as a vehicle for coronavirus proteins. Bharat Biotech claimed to have excellent track record of innovation with more than 140 global patents, a wide product portfolio of more than 16 vaccines, 4 bio-therapeutics, registrations in more than 116 countries and WHO Pre-qualifications. The company has so far developed vaccines for H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika and the world's first conjugated vaccine for Typhoid. It has delivered more than four billion doses of vaccines worldwide. It is also the largest Rabies vaccine manufacturer in the world. Another city-based firm Biological E last month initiated clinical trial of its COVID-19 subunit vaccine candidate in India following approval from the Drugs Controller General of India (DCGI). BE is making the vaccine in collaboration with <keyword id="5289395" type="COMPANY" weightage="20" keywordseo="dynavax-technologies-corporation">Dynavax Technologies Corporation</keyword> (Dynavax), a US-based vaccine focused biopharmaceutical company, and <keyword id="503459" type="COMPANY" weightage="20" keywordseo="Baylor-College-of-Medicine">Baylor College of Medicine</keyword>, a health sciences university in Houston. Biological E has also signed an agreement with Johnson &amp; Johnson to produce the latter's vaccine at its vaccine production facilities and sell them both in India and export across various global markets. Indian Immunologicals, a human and animal vaccines maker, too is developing a vaccine for COVID. Hyderabad-based pahrma major Dr Reddy's Laboratories is conducting clinical trials of Russian COVID-19 vaccine, Sputnik V. Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, has collaborated with Dr Reddy's to conduct clinical trials and distribute the vaccine in India. Hyderabad was under spotlight with the recent visits by Prime Minister Narendra Modi and ambassadors of more than 60 countries to the facilities of Bharat Biotech and Biological E in Genome Valley Telangana's industry minister K. T. Rama Rao believes that Hyderabad has cemented its position as the vaccine capital of the world. He pointed out that Hyderabad is already manufacturing more than two billion doses of vaccines every year, which is one-third of the global vaccine output. The city, with its strong ecosystem, has played a critical role in making India not only self-sufficient in the medicine manufacture but also turned it into the pharmacy capital of the world. It accounts for 40 per cent of the total Indian bulk drugs and 50 per cent of the bulk drug exports. Industry leaders believe that Hyderabad will be an integral part of the global efforts to vaccinate the world against COVID. Even if no vaccine is developed in the city, the city will still have a big role to play in global vaccination efforts with the sheer vaccine manufacturing capacity it houses. Hyderabad has the largest US FDA approved vaccine facilities. They have the capacity to manufacture millions of doses with world-class standards. "India's vaccine sector will play a critical role in developing and producing vaccine at scale for distribution across the world. Hyderabad's importance in the global vaccine landscape is only growing," K.T. Rama Rao said. Telangana government has assured the companies that it will play the enabling role in global vaccination efforts against COVID-19. The Hyderabad airport announced few days ago that has developed necessary infrastructure to handle the exports. As per the industry insights, most of India's vaccine export will be to Africa, Latin America and Asian destinations. Hyderabad is already home to more than 800 life sciences companies and the sector employs over 1,20,000 pharmaceutical professionals. It is said to be the only city in the country to house more than 20 incubation centres focused only on life sciences and health-tech. More than 200 start-ups are also working on innovative solutions in healthcare. Genome Valley is India's first organised cluster for life sciences R&amp;D activities spread across 600 square kilometers. Set up in 1999, it has world-class infrastructure facilities in the form of <keyword id="10464926" type="COMPANY" weightage="20" keywordseo="industrial-/-knowledge">Industrial / Knowledge</keyword> parks, Special Economic Zones (SEZs), Multi-tenanted dry and wet laboratories and incubation facilities. It is home to more than 200 companies including presence of the marquee global names like Novartis, GlaxoSmithKline, Ferring Pharma, Chemo, DuPont, Ashland, United States Pharmacopeia and Lonza. With <keyword id="4920024" type="LOCATION" weightage="20" keywordseo="Hyderabad-Pharma-City">Hyderabad Pharma City</keyword> also likely to be operational soon, the city is looking to ramp-up production of Active Pharmaceutical Ingredients (APIs) and thus develop a cluster to help the country compete with China. The new project is expected to create 1,70,000 direct jobs and 5,60,000 indirect jobs. SEE ALSO: <a href="https://www.businessinsider.in/tech/enterprise/news/wistron-apple-iphone-manufacturer-could-face-these-penalties-if-found-guilty/articleshow/79790319.cms">If investigators find Wistron management guilty, here's what is at stake for the company</a> <a href="https://www.businessinsider.in/stock-market/news/heres-what-analysts-say-if-you-should-subscribe-or-not-to-the-300-crore-ipo-of-antony-waste-handling-cell/articleshow/79790998.cms">Antony Waste Handling Cell ₹300-crore IPO will open on Monday— these are the risks and opportunities</a> <a href="https://www.businessinsider.in/business/news/ikea-india-cfo-says-she-still-has-3500-crore-to-be-spent-in-india-the-pandemic-has-changed-targets-but-not-the-investment-plan/articleshow/79790938.cms">INTERVIEW: Ikea CFO says she still has ₹3,500 crore to be spent in India⁠— the pandemic has changed targets but not the investment plan</a>

Hyderabad : Vaccine capital of the world

Kolkata Knight Riders (KKR) will have to get back to their winning ways when they take on defending champions Sunrisers Hyderabad (SRH) in the <keyword id="6354831" type="ORGANIZATION" weightage="20" keywordseo="Indian-Premier-League">Indian Premier League</keyword> (IPL) Eliminator at the M Chinnaswamy Stadium here on Wednesday.

IPL 2017, Playoffs Eliminator:
Kolkata collide with Hyderabad

Bollywood superstar <keyword id="6357912" type="General" weightage="100" keywordseo="amitabh-bachchan" source="Orion">Amitabh Bachchan</keyword> said that he sustained an injury during the shooting of his upcoming film, <keyword id="4155889" type="General" weightage="80" keywordseo="project-k" source="Orion">Project K</keyword>, in <keyword id="6354552" type="General" weightage="50" keywordseo="hyderabad" source="Orion">Hyderabad</keyword>. Big B took to his blog to share on Sunday that he has broken his rib cartilage and stated that he is currently taking rest at his home in Mumbai. "In Hyderabad at the shoot for Project K, during an action shot, got injured, rib cartilage popped broke and muscle tear to the right rib cage. Cancelled shoot, did doctor consult &amp; scan by CT at AIG Hospital in Hyderabad and flown back home," posted Amitabh Bachchan. He suffered an injury during an action sequence of the film. He, unfortunately, suffered a muscle tear to his right rib cage. "Strapping has been done and rest been advocated .. yes painful .. on movement and breathing .. will take some weeks they say before some normalisation will occur .. some medication is on also for pain .. So all work that was to be done has been suspended and canceled dropped postponed for the moment until healing occurs ..I rest at <keyword id="72038" type="General" weightage="80" keywordseo="jalsa" source="Orion">Jalsa</keyword> and am mobile a bit for all the essential activities .. but yes in rest and generally lying around ..." Big B wrote. Expressing his anguish the actor added, "It shall be difficult or let me say .. I shall be unable to meet, the well wishers at Jalsa Gate this evening .. so do not come .. and do inform as much as you can to those that intend coming ...All else is well ..." he posted. Helmed by Nag Ashwin, Project K is a bilingual film shot simultaneously in two languages i.e Hindi and Telugu across various locations. Deepika Padukone and Prabhash are playing pivotal roles in the film. In this time of distress, Amitabh Bachchan said he had found solace in his '<keyword id="314387" type="General" weightage="80" keywordseo="babuji" source="Orion">Babuji</keyword>' words. The actor wrote in his blog, "Getting time to spend time with Babuji and his genius, his mind his words and his immense creativity .. the essence of life resides in his writings .. and such a learning and amazed joy to be in his company ..There is desire to share .. to share what ever little that I may interpret from his words and his memories of the times spent with him .. to lament the limited .. to be in awe of the vision and the intellect of such a being .. and wonder how ever did one think of all that was written spoken thought by him .." SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/varanasi-tirupati-and-puri-are-favoured-destinations-in-spiritual-and-wellness-travel/articleshow/98444093.cms">Gen Zs &amp; Millennials aid spiritual &amp; wellness-driven tourism recovery in India</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/news/deals-on-headphones-speakers-tvs-and-smart-devices-on-amazon/articleshow/98444022.cms">Holi Sale 2023: Deals on headphones, speakers, TVs, and smart devices on Amazon</a>

Amitabh Bachchan injured during film shoot in Hyderabad

Ticket sales began on Wednesday for the first-ever ABB FIA Formula E World Championship race in <keyword id="3658" type="General" weightage="50" keywordseo="india" source="Orion">India</keyword> to be held in <keyword id="6354552" type="General" weightage="100" keywordseo="hyderabad" source="Orion">Hyderabad</keyword> on February 11. Telangana Government's Special Chief Secretary (Municipal Administration) <keyword id="140987" type="General" weightage="50" keywordseo="arvind-kumar" source="Orion">Arvind Kumar</keyword> booked the first ticket at an event here. The "world's fastest, lightest, most powerful and efficient electric race car - the Gen3" is coming to Hyderabad on February 11 for the event, a press release issued by the organisers said. Private firm <keyword id="15434652" type="General" weightage="50" keywordseo="ace-nxt-gen" source="Orion">Ace Nxt Gen</keyword> is the official promoter of the <keyword id="7123812" type="General" weightage="80" keywordseo="formula-e-race" source="Orion">Formula E Race</keyword> in India in partnership with Formula E and the Telangana government. Speaking on the occasion, Kumar said the event would place Hyderabad as a global destination for e-mobility. A total of 11 teams with 22 cars would be racing here and they include some of the top racing companies, he said. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/sports/news/india-won-the-first-t20i-against-sri-lanka-in-a-nail-biting-finish/slidelist/96733749.cms">India won the first T20I against Sri Lanka in a nail biting finish</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/ms-dhoni-backed-drone-firm-garuda-aerospace-launches-farmers-focused-film/articleshow/96734751.cms">MS Dhoni-backed drone firm Garuda Aerospace launches farmers-focused film</a>

Tickets sales start for India's first-ever Formula E race in Hyderabad

Defending champions Sunrisers Hyderabad will be desperate to win their final home match here on Monday against top-placed Mumbai Indians in order to seal their play-offs berth of the ongoing Indian Premier League (IPL). 
 
Hyderabad have 13 points from 12 matches and are fourth in the points table. One more win will likely take them through to the play-offs and. due to their superb home record, they will be eager to bag two points at the Rajiv Gandhi International Stadium here.

You Searched For "Hyderabad" and got 5 results

Hyderabad : Vaccine capital of the world

IANS

IPL 2017, Playoffs Eliminator: Kolkata collide with Hyderabad

Gaurav Sangwani

Amitabh Bachchan injured during film shoot in Hyderabad

ANI

Tickets sales start for India's first-ever Formula E race in Hyderabad

PTI

IPL 2017, SRH vs MI: Hyderabad looking to confirm their playoffs place against ‘top placed’ Mumbai

Gaurav Sangwani

Popular Keywords

Buying Guides